Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Timing matters when it comes to retirement planning. Learn when you should start planning to maximize your savings and ensure a secure future.
26,056 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Oklo is developing compact nuclear reactors geared for AI data centers. This article lays out a grounded five-year ro...
WTRG just released its quarterly earnings, and the market is parsing revenue growth, margins, and forward guidance. T...
Investors are buzzing about Micron Technology as AI and data-center demand shift the memory market. This article expl...
This in-depth look examines the factors behind wallbox (wbx) 2025 earnings and what they mean for investors. Learn ab...
A massive stockpile of used nuclear fuel sits in storage, but new tech could turn that waste into energy. This invest...
META sits at a pivotal moment. With AI-enabled engagement, ad momentum, and new monetization paths, analysts wonder i...
Discover how orion properties (onl) 2025 earnings shape investor decisions. This analysis breaks down revenue drivers...
This article breaks down surf mobility (SRFM) earnings in plain language. Learn what the SRFM earnings transcript rev...
Biotech stocks can swing on earnings surprises. This article explains why lenz therapeutics stock crashed, what it me...
Zebra Technologies stock jumped sharply this morning after a solid Q1 2026 report. This article breaks down the numbe...
Drones and government funding chatter are reshaping investor sentiment. Ondas is at the center of the action, with ot...